{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:25:49Z","timestamp":1789068349375,"version":"build-2803163510"},"reference-count":139,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.seminhematol.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T02:25:04Z","timestamp":1710815104000},"page":"181-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["miRNA Biology in Chronic Lymphocytic Leukemia"],"prefix":"10.1053","volume":"61","author":[{"given":"Recep","family":"Bayraktar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Calin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5009-6149","authenticated-orcid":false,"given":"Kinga","family":"Nemeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2024.03.001_bib0001","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0002","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1126\/science.1149460","article-title":"Switching from repression to activation: microRNAs can up-regulate translation","volume":"318","author":"Vasudevan","year":"2007","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0003","first-page":"1","article-title":"Non-coding RNAs in disease: from mechanisms to therapeutics","author":"Nemeth","year":"2023","journal-title":"Nat Rev Genet"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Sig Transduct Target Ther"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0005","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41571-019-0239-8","article-title":"Chronic lymphocytic leukaemia: from genetics to treatment","volume":"16","author":"Bosch","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0006","series-title":"Cancer Stat Facts - Chronic Lymphocytic Leukemia 2023","year":"2023"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0007","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0008","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0009","doi-asserted-by":"crossref","first-page":"60986","DOI":"10.18632\/oncotarget.11290","article-title":"Role of mir-15a\/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia","volume":"7","author":"Underbayev","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0010","doi-asserted-by":"crossref","first-page":"8433","DOI":"10.1158\/0008-5472.CAN-07-1585","article-title":"MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth","volume":"67","author":"Corney","year":"2007","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0011","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1073\/pnas.1500010112","article-title":"TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia","volume":"112","author":"Balatti","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0012","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network","volume":"447","author":"He","year":"2007","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0013","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/leu.2008.377","article-title":"miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities","volume":"23","author":"Mraz","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0014","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1158\/0008-5472.CAN-12-0803","article-title":"Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia","volume":"72","author":"Baer","year":"2012","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0015","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0016","doi-asserted-by":"crossref","first-page":"11755","DOI":"10.1073\/pnas.0404432101","article-title":"MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040593","article-title":"MicroRNAs: Tiny Regulators of Gene Expression with Pivotal Roles in Normal B-Cell Development and B-Cell Chronic Lymphocytic Leukemia","volume":"13","author":"Katsaraki","year":"2021","journal-title":"Cancers"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0018","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2014-12-618025","article-title":"Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts","volume":"126","author":"Paggetti","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10555-017-9724-7","article-title":"miR-155 in cancer drug resistance and as target for miRNA-based therapeutics","volume":"37","author":"Bayraktar","year":"2018","journal-title":"Cancer Metastasis Rev"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0020","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2014-03-559690","article-title":"MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia","volume":"124","author":"Cui","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0021","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2010-01-263889","article-title":"microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival","volume":"116","author":"Rossi","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0022","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1182\/blood-2010-05-285064","article-title":"MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia","volume":"117","author":"Vargova","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0023","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2013-01-478222","article-title":"Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia","volume":"122","author":"Ferrajoli","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0024","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/leu.2014.344","article-title":"miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib","volume":"29","author":"Guinn","year":"2015","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0025","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2012-02-410647","article-title":"LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0026","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ijc.32894","article-title":"Serum levels of hsa-miR-16-5p, hsa-miR-29a-3p, hsa-miR-150-5p, hsa-miR-155-5p and hsa-miR-223-3p and subsequent risk of chronic lymphocytic leukemia in the EPIC study","volume":"147","author":"Casabonne","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0027","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1038\/s41598-017-12135-7","article-title":"Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia","volume":"7","author":"Carabia","year":"2017","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0028","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-4598-9-123","article-title":"MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia","volume":"9","author":"Ferracin","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0029","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/leu.2014.158","article-title":"Activation of the PI3K\/AKT pathway by microRNA-22 results in CLL B-cell proliferation","volume":"29","author":"Palacios","year":"2015","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0030","doi-asserted-by":"crossref","first-page":"e10859","DOI":"10.1371\/journal.pone.0010859","article-title":"miR-22 Forms a Regulatory Loop in PTEN\/AKT Pathway and Modulates Signaling Kinetics","volume":"5","author":"Bar","year":"2010","journal-title":"PLoS One"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0031","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3109\/10428194.2014.990900","article-title":"Dissecting chronic lymphocytic leukemia microenvironment signals in patients with unmutated disease: microRNA-22 regulates phosphatase and tensin homolog\/AKT\/FOXO1 pathway in proliferative leukemic cells","volume":"56","author":"Palacios","year":"2015","journal-title":"Leukemia & Lymphoma"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0032","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12288-016-0694-7","article-title":"Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia","volume":"33","author":"Dehkordi","year":"2017","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0033","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood-2009-11-254656","article-title":"MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221\/222 cluster and p27","volume":"115","author":"Frenquelli","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0034","doi-asserted-by":"crossref","first-page":"6573","DOI":"10.1073\/pnas.1019557108","article-title":"MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia","volume":"108","author":"Moussay","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.52547\/rbmb.10.1.20","article-title":"Alterations in The Plasma Expression of mir-15b, mir-195 and the Tumor-Suppressor Gene DLEU7 in Patients with B-Cell Chronic Lymphocytic Leukemia","volume":"10","author":"Bagheri","year":"2021","journal-title":"Rep Biochem Mol Biol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0036","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V110.11.3183.3183","article-title":"Up-Regulation of miR-195 Expression Leads to Decreased Expression of Basic Fibroblast Growth Factor in CLL Patients Treated with DNA Methylation Inhibitors","volume":"110","author":"Phillips","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0037","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/gcc.22236","article-title":"Increased chronic lymphocytic leukemia proliferation upon IgM stimulation is sustained by the upregulation of miR-132 and miR-212","volume":"54","author":"Tavolaro","year":"2015","journal-title":"Genes, Chromosomes and Cancer"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0038","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1182\/blood-2018-04-845115","article-title":"miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients","volume":"132","author":"Balatti","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0039","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/leu.2015.119","article-title":"p53-dependent non-coding RNA networks in chronic lymphocytic leukemia","volume":"29","author":"Blume","year":"2015","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0040","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/ijms24021705","article-title":"Prognostic Value of the miR-17\u223c92 Cluster in Chronic Lymphocytic Leukemia","volume":"24","author":"Chocholska","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0041","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/JBM.S230842","article-title":"Serum Expression of Seven MicroRNAs in Chronic Lymphocytic Leukemia Patients","volume":"11","author":"Farzadfard","year":"2020","journal-title":"J Blood Med"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0042","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1182\/blood-2011-09-378687","article-title":"The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice","volume":"119","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141429","article-title":"CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p","volume":"10","author":"Farahani","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0044","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","article-title":"Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181","volume":"66","author":"Pekarsky","year":"2006","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0045","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1182\/blood-2011-01-333484","article-title":"miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia","volume":"118","author":"Visone","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0046","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/cancers13020257","article-title":"Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response","volume":"13","author":"Di Marco","year":"2021","journal-title":"Cancers"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0047","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.20080579","article-title":"miR-181b negatively regulates activation-induced cytidine deaminase in B cells","volume":"205","author":"de Y\u00e9benes","year":"2008","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0048","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/carcin\/bgs179","article-title":"miR-181a\/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes","volume":"33","author":"Zhu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0049","doi-asserted-by":"crossref","first-page":"19807","DOI":"10.18632\/oncotarget.4415","article-title":"miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the E\u03bc-TCL1 mouse model","volume":"6","author":"Bresin","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0050","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/ijc.29491","article-title":"Epigenetic silencing of miR-708 enhances NF-\u03baB signaling in chronic lymphocytic leukemia","volume":"137","author":"Baer","year":"2015","journal-title":"International Journal of Cancer"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0051","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s43046-021-00097-x","article-title":"Prognostic significance of microRNA 17-92 cluster expression in Egyptian chronic lymphocytic leukemia patients","volume":"33","author":"Khalifa","year":"2021","journal-title":"J Egypt Natl Canc Inst"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0052","doi-asserted-by":"crossref","first-page":"19381","DOI":"10.18632\/oncotarget.4574","article-title":"The MYC\/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential","volume":"6","author":"Dal Bo","year":"2015","journal-title":"Oncotarget"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0053","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/10428194.2018.1461861","article-title":"MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia","volume":"60","author":"Papageorgiou","year":"2019","journal-title":"Leukemia & Lymphoma"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0054","doi-asserted-by":"crossref","first-page":"e16956","DOI":"10.1371\/journal.pone.0016956","article-title":"MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0055","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood.2020005627","article-title":"miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors","volume":"137","author":"Sharma","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0056","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1182\/bloodadvances.2021005726","article-title":"MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells","volume":"6","author":"Matis","year":"2022","journal-title":"Blood Advances"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0057","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/cam4.996","article-title":"The regulation of tumor-suppressive microRNA, miR-126, in chronic lymphocytic leukemia","volume":"6","author":"Guinn","year":"2017","journal-title":"Cancer Medicine"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0058","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0059","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.21037\/tcr-20-1710","article-title":"A feedback circuit of miR-34a\/MDM4\/p53 regulates apoptosis in chronic lymphocytic leukemia cells","volume":"9","author":"Cao","year":"2020","journal-title":"Transl Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0060","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1182\/blood-2008-08-172254","article-title":"miR-34a as part of the resistance network in chronic lymphocytic leukemia","volume":"113","author":"Zenz","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0061","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2009-07-234823","article-title":"microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia","volume":"115","author":"Asslaber","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0062","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-04-845115","article-title":"miR-125a and miR-34a expression predicts Richter syndrome in chronic lymphocytic leukemia patients","volume":"132","author":"Balatti","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0063","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41375-018-0230-x","article-title":"MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells","volume":"33","author":"Cerna","year":"2019","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0064","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1479-5876-12-52","article-title":"Epigenetic inactivation of mir-34b\/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia","volume":"12","author":"Wang","year":"2014","journal-title":"J Transl Med"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0065","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4161\/epi.28603","article-title":"microRNA-34b\/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia","volume":"9","author":"Deneberg","year":"2014","journal-title":"Epigenetics"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0066","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1038\/leu.2009.125","article-title":"miR-34b\/miR-34c: a regulator of TCL1 expression in 11q\u2212 chronic lymphocytic leukaemia?","volume":"23","author":"Cardinaud","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0067","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2012-03-415737","article-title":"The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state","volume":"120","author":"Tili","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0068","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1182\/blood-2013-09-527234","article-title":"miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1","volume":"124","author":"Mraz","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0069","doi-asserted-by":"crossref","first-page":"10731","DOI":"10.1073\/pnas.1708264114","article-title":"MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia","volume":"114","author":"Rassenti","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0070","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/bjh.13043","article-title":"Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia","volume":"167","author":"Lin","year":"2014","journal-title":"British Journal of Haematology"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0071","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.biopha.2017.05.144","article-title":"Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia","volume":"92","author":"Braga","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0072","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2217\/bmm-2021-0873","article-title":"miR-197, miR-26a and miR-27a analysis in chronic lymphocytic leukemia","volume":"16","author":"C Andrade","year":"2022","journal-title":"Biomark Med"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0073","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13104-020-05428-0","article-title":"Evaluation of microRNA-223 and microRNA-125a expression association with STAT3 and Bcl2 genes in blood leukocytes of CLL patients: a case\u2013control study","volume":"14","author":"Davari","year":"2021","journal-title":"BMC Res Notes"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0074","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/1078-0432.CCR-13-2497","article-title":"microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters","volume":"20","author":"Negrini","year":"2014","journal-title":"Clinical Cancer Research"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0075","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/cancers14071676","article-title":"TGF-\u03b2\/SMAD Pathway Is Modulated by miR-26b-5p: Another Piece in the Puzzle of Chronic Lymphocytic Leukemia Progression","volume":"14","author":"Marquez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0076","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.omto.2020.01.004","article-title":"Differential Expression Profile of miR-27b, miR-29a, and miR-155 in Chronic Lymphocytic Leukemia and Breast Cancer Patients","volume":"16","author":"Raeisi","year":"2020","journal-title":"Molecular Therapy - Oncolytics"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0077","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-019-0272-y","article-title":"RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome","volume":"10","author":"Kaur","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0078","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.leu.2405022","article-title":"Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis","volume":"22","author":"Marton","year":"2008","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0079","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3892\/etm.2020.8771","article-title":"MicroRNA\u2011425 inhibits proliferation of chronic lymphocytic leukaemia cells through regulation of the Bruton's tyrosine kinase\/phospholipase C\u03b32 signalling pathway","volume":"20","author":"Chen","year":"2020","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0080","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/molecules28010116","article-title":"Drug Resistance: The Role of Exosomal miRNA in the Microenvironment of Hematopoietic Tumors","volume":"28","author":"Cariello","year":"2022","journal-title":"Molecules"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0081","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jb\/mvaa064","article-title":"Exosomes derived from chronic lymphocytic leukaemia cells transfer miR-146a to induce the transition of mesenchymal stromal cells into cancer-associated fibroblasts","volume":"168","author":"Yang","year":"2020","journal-title":"The Journal of Biochemistry"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0082","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2308658120","article-title":"Complete miRNA-15\/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state","volume":"120","author":"Ng","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0083","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.bjc.6605193","article-title":"Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype","volume":"101","author":"Grelier","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0084","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2559.2011.04110.x","article-title":"Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer","volume":"61","author":"Faggad","year":"2012","journal-title":"Histopathology"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0085","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1349-7006.2012.02234.x","article-title":"Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia","volume":"103","author":"Zhu","year":"2012","journal-title":"Cancer Sci"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0086","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood-2011-05-351510","article-title":"Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia","volume":"119","author":"Sampath","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0087","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41375-020-0995-6","article-title":"RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia","volume":"35","author":"Gassner","year":"2021","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0088","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3390\/cancers12051159","article-title":"RNA Editing Alters miRNA Function in Chronic Lymphocytic Leukemia","volume":"12","author":"Gassner","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0089","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40364-020-00222-3","article-title":"Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia","volume":"8","author":"Yun","year":"2020","journal-title":"Biomark Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/cdd.2014.87","article-title":"Role of miR-15\/16 in CLL","volume":"22","author":"Pekarsky","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0091","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0092","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","article-title":"Evolution and impact of subclonal mutations in chronic lymphocytic leukemia","volume":"152","author":"Landau","year":"2013","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0093","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2022.12581","article-title":"Inside the chronic lymphocytic leukemia cell: miRNA and chromosomal aberrations","volume":"25","author":"Grenda","year":"2022","journal-title":"Molecular Medicine Reports"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0095","first-page":"27","article-title":"Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update","volume":"9","author":"Bayraktar","year":"2023","journal-title":"Noncoding RNA"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0096","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/gene.2011.58","article-title":"Systemic in vivo lentiviral delivery of miR-15a\/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia","volume":"13","author":"Kasar","year":"2012","journal-title":"Genes Immun"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0097","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/leu.2016.394","article-title":"Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy","volume":"31","author":"Cutrona","year":"2017","journal-title":"Leukemia"},{"issue":"Suppl","key":"10.1053\/j.seminhematol.2024.03.001_bib0098","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.clml.2015.02.010","article-title":"Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1","volume":"15","author":"Choi","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0099","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1182\/blood.2018882290","article-title":"ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model","volume":"134","author":"Chiang","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0100","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-17-1959","article-title":"Dual Suppressive Effect of miR-34a on the FOXM1\/eEF2-Kinase Axis Regulates Triple-Negative Breast Cancer Growth and Invasion","volume":"24","author":"Bayraktar","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0101","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1038\/mtna.2014.47","article-title":"Mir-34: a new weapon against cancer?","volume":"3","author":"Misso","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0102","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0103","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.3390\/ijms23052805","article-title":"miRNAs in Cancer (Review of Literature)","volume":"23","author":"Smolarz","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0104","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1038\/s41598-018-30989-3","article-title":"OncomiR-10b hijacks the small molecule inhibitor linifanib in human cancers","volume":"8","author":"Monroig-Bosque","year":"2018","journal-title":"Sci Rep"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0106","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood.V128.22.1829.1829","article-title":"Preliminary Results of a Phase 1 Trial Evaluating MRG-106, a Synthetic microRNA Antagonist (LNA antimiR) of microRNA-155, in Patients with CTCL","volume":"128","author":"Querfeld","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0107","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-20-3139","article-title":"Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth In Vitro and In Vivo","volume":"27","author":"Anastasiadou","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13045-014-0079-z","article-title":"Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia","volume":"7","author":"Dereani","year":"2014","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0109","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3324\/haematol.2016.153189","article-title":"miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study","volume":"102","author":"Gagez","year":"2017","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1476-4598-9-115","article-title":"Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia","volume":"9","author":"Moussay","year":"2010","journal-title":"Mol Cancer"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0111","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.2147\/CMAR.S191311","article-title":"Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients","volume":"11","author":"Szymczyk","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0112","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/1078-0432.CCR-12-1922","article-title":"In vitro sensitivity of CLL cells to fludarabine may be modulated by the stimulation of Toll-like receptors","volume":"19","author":"Fonte","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0113","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1476-4598-12-52","article-title":"Fludarabine treatment favors the retention of miR-485-3p by prostate cancer cells: implications for survival","volume":"12","author":"Lucotti","year":"2013","journal-title":"Mol Cancer"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0114","doi-asserted-by":"crossref","first-page":"525","DOI":"10.6004\/jadpro.2022.13.5.6","article-title":"Richter Transformation: Clinical Manifestations, Evaluation, and Management","volume":"13","author":"Douglas","year":"2022","journal-title":"J Adv Pract Oncol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0115","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/AJCPIVKZRMPF93ET","article-title":"Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma With Cyclin D1 Positive Proliferation Centers Do Not Have CCND1 Translocations or Gains and Lack SOX11 Expression","volume":"138","author":"Gradowski","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0116","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/hematology.2022000345","article-title":"Treatment of Richter's syndrome","volume":"2022","author":"Thompson","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0117","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1200\/JCO.2005.05.0187","article-title":"Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation","volume":"24","author":"Tsimberidou","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0118","first-page":"2995","article-title":"Clinical Outcome and Prognostic Factors of Patients with Richter's Syndrome: Retrospective Multicenter Study of the Spanish Chronic Lymphocytic Leukemia (CLL) Study Group (GELLC)","volume":"130","author":"Abrisqueta","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0119","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0120","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1182\/blood-2018-01-791376","article-title":"Biology and treatment of Richter syndrome","volume":"131","author":"Rossi","year":"2018","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0121","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2013-03-489518","article-title":"Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome","volume":"122","author":"Chigrinova","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0122","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3324\/haematol.2018.203828","article-title":"The involvement of microRNA in the pathogenesis of Richter syndrome","volume":"104","author":"Van Roosbroeck","year":"2019","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0123","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.829983","article-title":"Biology and Treatment of Richter Transformation","volume":"12","author":"Condoluci","year":"2022","journal-title":"Front Oncol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0124","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hon.932","article-title":"Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas","volume":"28","author":"Scandurra","year":"2010","journal-title":"Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10408363.2018.1499707","article-title":"Exosome-carried microRNA-based signature as a cellular trigger for the evolution of chronic lymphocytic leukemia into Richter syndrome","volume":"55","author":"Jurj","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0126","doi-asserted-by":"crossref","unstructured":"Madhumita M, Paul S. A review on methods for predicting miRNA\u2013mRNA regulatory modules. J Integr Bioinform n.d.;19:20200048. https:\/\/doi.org\/10.1515\/jib-2020-0048.","DOI":"10.1515\/jib-2020-0048"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0127","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2014.00023","article-title":"Common features of microRNA target prediction tools","volume":"5","author":"Peterson","year":"2014","journal-title":"Frontiers in Genetics"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0128","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0092-8674(03)01018-3","article-title":"Prediction of Mammalian MicroRNA Targets","volume":"115","author":"Lewis","year":"2003","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0129","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2174\/138920209789208219","article-title":"Survey of Computational Algorithms for MicroRNA Target Prediction","volume":"10","author":"Yue","year":"2009","journal-title":"CG"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0130","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature03315","article-title":"Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs","volume":"433","author":"Lim","year":"2005","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0131","doi-asserted-by":"crossref","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0132","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/gb-2003-5-1-r1","article-title":"MicroRNA targets in Drosophila","volume":"5","author":"Enright","year":"2003","journal-title":"Genome Biology"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0133","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206239","article-title":"miRWalk: An online resource for prediction of microRNA binding sites","volume":"13","author":"Sticht","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0135","doi-asserted-by":"crossref","first-page":"D304","DOI":"10.1093\/nar\/gkad1071","article-title":"TarBase-v9.0 extends experimentally supported miRNA\u2013gene interactions to cell-types and virally encoded miRNAs","volume":"52","author":"Skoufos","year":"2024","journal-title":"Nucleic Acids Research"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0136","doi-asserted-by":"crossref","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions","volume":"50","author":"Huang","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0137","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/nsmb.2115","article-title":"Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs","volume":"18","author":"Garcia","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0138","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/gb-2010-11-8-r90","article-title":"Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites","volume":"11","author":"Betel","year":"2010","journal-title":"Genome Biol"},{"key":"10.1053\/j.seminhematol.2024.03.001_bib0139","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1093\/bioinformatics\/bty424","article-title":"DeepMirTar: a deep-learning approach for predicting human miRNA targets","volume":"34","author":"Wen","year":"2018","journal-title":"Bioinformatics"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:19:49Z","timestamp":1720531189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0037196324000544"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.03.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miRNA Biology in Chronic Lymphocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}